PharmacoEconomics & Outcomes News Weekly

, Volume 205, Issue 1, pp 3–4 | Cite as

Understanding attitudes about biotechnology drugs

  • Mark Greener
Newsletter Article


T he fruits of biotechnological research are having a growing impact on the pharmaceutical market.* However, a recent study found that doctors don’t apply the same decision-making process to biotechnological products as they use for conventional pharmaceuticals. The study suggests that understanding these differences could help purchasers and prescribers work together to optimise outcomes when using biotechnology drugs. For example, formulary management strategies for biotechnological products should place greater emphasis on clinical and humanistic outcomes than cost.


Growth Hormone Human Growth Hormone Biotechnological Product Growth Hormone Replacement Traditional Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1999

Authors and Affiliations

  • Mark Greener

There are no affiliations available

Personalised recommendations